274 related articles for article (PubMed ID: 32139692)
1. Assessing auditory processing endophenotypes associated with Schizophrenia in individuals with 22q11.2 deletion syndrome.
Francisco AA; Foxe JJ; Horsthuis DJ; DeMaio D; Molholm S
Transl Psychiatry; 2020 Mar; 10(1):85. PubMed ID: 32139692
[TBL] [Abstract][Full Text] [Related]
2. Altered auditory processing and effective connectivity in 22q11.2 deletion syndrome.
Larsen KM; Mørup M; Birknow MR; Fischer E; Hulme O; Vangkilde A; Schmock H; Baaré WFC; Didriksen M; Olsen L; Werge T; Siebner HR; Garrido MI
Schizophr Res; 2018 Jul; 197():328-336. PubMed ID: 29395612
[TBL] [Abstract][Full Text] [Related]
3. Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk.
Francisco AA; Horsthuis DJ; Popiel M; Foxe JJ; Molholm S
Neuroimage Clin; 2020; 27():102351. PubMed ID: 32731196
[TBL] [Abstract][Full Text] [Related]
4. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.
Zarchi O; Carmel M; Avni C; Attias J; Frisch A; Michaelovsky E; Patya M; Green T; Weinberger R; Weizman A; Gothelf D
J Psychiatr Res; 2013 Nov; 47(11):1623-9. PubMed ID: 23910792
[TBL] [Abstract][Full Text] [Related]
6. Event-related potential (ERP) markers of 22q11.2 deletion syndrome and associated psychosis.
Francisco AA; Foxe JJ; Molholm S
J Neurodev Disord; 2023 Jun; 15(1):19. PubMed ID: 37328766
[TBL] [Abstract][Full Text] [Related]
7. Abnormal Auditory Processing and Underlying Structural Changes in 22q11.2 Deletion Syndrome.
Cantonas LM; Mancini V; Rihs TA; Rochas V; Schneider M; Eliez S; Michel CM
Schizophr Bull; 2021 Jan; 47(1):189-196. PubMed ID: 32747926
[TBL] [Abstract][Full Text] [Related]
8. Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.
Parker DA; Cubells JF; Imes SL; Ruban GA; Henshey BT; Massa NM; Walker EF; Duncan EJ; Ousley OY
BMC Psychiatry; 2023 Jun; 23(1):425. PubMed ID: 37312091
[TBL] [Abstract][Full Text] [Related]
9. Blood brain barrier permeability increases with age in individuals with 22q11.2 deletion syndrome.
Taler M; Mekori-Domachevsky E; Vergaelen E; Claes S; Serur Y; Dar S; Levy-Shraga Y; Weizman A; Swillen A; Gothelf D
World J Biol Psychiatry; 2022 Jul; 23(6):475-482. PubMed ID: 34854358
[TBL] [Abstract][Full Text] [Related]
10. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
Mekori-Domachevsky E; Taler M; Shoenfeld Y; Gurevich M; Sonis P; Weisman O; Weizman A; Gothelf D
J Clin Psychiatry; 2017; 78(9):e1219-e1225. PubMed ID: 29141125
[TBL] [Abstract][Full Text] [Related]
11. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
Gothelf D; Law AJ; Frisch A; Chen J; Zarchi O; Michaelovsky E; Ren-Patterson R; Lipska BK; Carmel M; Kolachana B; Weizman A; Weinberger DR
Biol Psychiatry; 2014 Mar; 75(5):406-13. PubMed ID: 23992923
[TBL] [Abstract][Full Text] [Related]
12. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.
Van L; Boot E; Bassett AS
Curr Opin Psychiatry; 2017 May; 30(3):191-196. PubMed ID: 28230630
[TBL] [Abstract][Full Text] [Related]
13. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
[TBL] [Abstract][Full Text] [Related]
14. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils to lymphocytes ratio and psychosis in 22q11.2 deletion syndrome - Clinical and scientific implications.
Mekori-Domachevsky E; Taler M; Weinberger R; Guri Y; Dar S; Shani S; Dekel I; Weizman A; Gothelf D
Schizophr Res; 2021 May; 231():164-169. PubMed ID: 33866261
[TBL] [Abstract][Full Text] [Related]
16. A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?
Vergaelen E; Schiweck C; Van Steeland K; Counotte J; Veling W; Swillen A; Drexhage H; Claes S
Brain Behav Immun; 2018 May; 70():88-95. PubMed ID: 29567371
[TBL] [Abstract][Full Text] [Related]
17. Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms.
Donnelly NA; Bartsch U; Moulding HA; Eaton C; Marston H; Hall JH; Hall J; Owen MJ; van den Bree MBM; Jones MW
Elife; 2022 Aug; 11():. PubMed ID: 36039635
[TBL] [Abstract][Full Text] [Related]
18. Visual processing deficits in 22q11.2 Deletion Syndrome.
Biria M; Tomescu MI; Custo A; Cantonas LM; Song KW; Schneider M; Murray MM; Eliez S; Michel CM; Rihs TA
Neuroimage Clin; 2018; 17():976-986. PubMed ID: 29527499
[TBL] [Abstract][Full Text] [Related]
19. Cognitive behavioral therapy in 22q11.2 microdeletion with psychotic symptoms: What do we learn from schizophrenia?
Demily C; Franck N
Eur J Med Genet; 2016 Nov; 59(11):596-603. PubMed ID: 27639442
[TBL] [Abstract][Full Text] [Related]
20. Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study.
Gothelf D; Penniman L; Gu E; Eliez S; Reiss AL
Schizophr Res; 2007 Nov; 96(1-3):72-81. PubMed ID: 17804201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
